Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board

  09 October 2019

We propose the establishment of a new Developing Antibiotics for Resistant Targets (DART) Board to improve the targeting of incentives for antibiotic development. The DART Board would comprise clinical experts, patient advocates, and representatives from government, industry, and nonprofit organizations.

Author(s): Brad Spellberg, MD; Travis B. Nielsen, PhD; David N. Gilbert, MD; Andrew F. Shorr, MD, MPH, MBA; Eric P. Brass, MD, PhD
Smart Innovations  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!